Recurrent ulcer

Also found in: Encyclopedia.

marginal ulcer

A term of art for ulcers that develop at the margins of a gastrojejunostomy, primarily on the jejunal side. Most marginal ulcers respond to medical therapy, but complicated or complex lesions require further intervention.

Surgical management
• Omental (Graham) patch repair;
• Revision of gastrojejunostomy;
• Irrigation and drainage;
• Any prior procedure with truncal vagotomy;
• Oesophagojejunostomy; and
• Reversal.

Recurrent ulcer

Stomach ulcers that return after apparently complete healing. These ulcers appear to be caused by helicobacter pylori infections and can generally be successfully treated with a combination of antibiotics and gastric acid reducing compounds, particularly the proton pump inhibitors.

Mentioned in: Proton Pump Inhibitors

Mentioned in ?

References in periodicals archive ?

He also talked about recurrent ulcers. Total destruction of a weight bearing joint is marked by bony destruction, Charcot osteoarthropathy is most overlooked serious limb-threatening complication of diabetes - Prof.Bilal Bin Younis bone resorption and eventual deformity.

Proceedings of NADEP Diabetes Foot Conference held at Lahore, Pakistan (August 10-12, 2018)

pylori infection) remained predictors for recurrent ulcer in patients with previous gastric surgery for PUD in our work, except for alcohol consumption and biliary reflux.

Factors Associated with Recurrent Ulcers in Patients with Gastric Surgery after More Than 15 Years: A Cross-Sectional Single-Center Study

Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis.

Gastrointestinal and cardiovascular risk of nonsteroidal anti-inflammatory drugs

Research has shown that a significant number of patients with atherosclerosis who have a history of peptic ulcer will develop recurrent ulcers during treatment with clopidogrel.

PPI may safely prevent ulcers in clopidogrel users

Combination of a cyclo-oxygenase-2 inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a randomised double-blind trial.

Serious gastrointestinal and cardiovascular events associated with non-steroidal anti-inflammatory drugs

This recommendation has been controversial, but current evidence suggests this strategy reduces the risk of recurrent ulcer bleeding.

Reducing gastrointestinal risks of NSAID therapy

Prevention of recurrent ulcer bleeding in H pylori-negative patients with arthritis

Updates on the management of upper gastrointestinal disorders in the primary care setting: NSAID-related gastropathies and pediatric reflux disease

Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding.

Aspirin plus PPI safer than clopidogrel if there is history of GI bleeding

The 13-month cumulative incidence of recurrent ulcer bleeding in this trial was 0% in subjects randomized to the combination therapy, compared with 8.9% in controls on celecoxib (Celebrex) plus placebo, Dr.

Celecoxib plus PPI protects against NSAID ulcers

The primary outcome was recurrent ulcer bleeding within 6 months.

What is the best NSAID regimen for arthritis patients with bleeding ulcer? (Patient Oriented Evidence That Matters: practice recommendations from key studies)

Chan, M.D., of the Chinese University of Hong Kong and his associates reported that recurrent ulcer bleeding occurred at a significantly higher rate in 161 patients who received clopidogrel (Plavix) plus a placebo than in 159 patients who received aspirin plus esomeprazole (Nexium) during a median follow-up of 12 months (8.6% vs.

Preventing recurrent ulcer bleeding

pylori eradication is associated with a low rate of recurrent ulcer hemorrhage and suggest that H.

Eradicating H. pylori may prevent bleeding ulcers: no [Histamine.sub.2] blockers needed. (Helicobacter)